A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.

ABSTRACT:

Objectives

Patients with diabetes mellitus are at a risk for hypoglycaemia. Besides the burden of hypoglycaemia for patients, hypoglycaemia poses an economic burden to society. The aim of this study was to calculate the per patient societal costs of hypoglycaemia among patients with type1 diabetes (T1DM) and type 2 diabetes (T2DM) on insulin therapy in the Netherlands.

Methods

To calculate the costs of hypoglycaemia, data from the Global Hypoglycaemia Assessment Tool (HAT) study were used. Dutch patients were selected from the HAT study database and data regarding healthcare resource use, informal care use and productivity losses were combined with Dutch unit costs to calculate the per patient 4-week costs of patients experiencing hypoglycaemia. Besides these 4-week costs, c

SUBMITTER: de Groot S 

PROVIDER: S-EPMC5875590 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature